Extending FDA-approved cancer drug indications requires high patient numbers, study finds Post author: Post published:September 29, 2023 Post category:uncategorized Number of patient participants needed for secondary approval of a new cancer drug. You Might Also Like Study shows milk, eggs and fish boost child development in Africa December 2, 2024 Study confirms bariatric surgery is safe and effective for patients with BMI over 70 November 22, 2024 DiaCarta partners with OncoAssure for prostate cancer test commercialization February 27, 2024
Study confirms bariatric surgery is safe and effective for patients with BMI over 70 November 22, 2024